| Document Date: 2013-07-29 10:52:47
Open Document File Size: 231,54 KBShare Result on Facebook
City Philadelphia / Norristown / / Company Hemispherx Biopharma Inc. / Pulse Biomedical Inc. / Brodsky / / Event Judicial Event / / Facility Philadelphia College of Osteopathic Medicine Philadelphia / / MedicalCondition fatigue / Heart failure / Torsades de Pointes / disease / disorder / extreme fatigue / Chronic Fatigue Syndrome / chronic / heart disease / cardiovascular disease / / MedicalTreatment polypharmacy / / Organization FDA / Philadelphia College of Osteopathic Medicine Philadelphia / / Person Bruce C. Stouch / David Strayer / Carter W. Targeting / Placebo Patients / Gerberding / / Position Fisher / exercise physiologist / / ProgrammingLanguage SAS System / / ProvinceOrState Pennsylvania / / PublishedMedium Annals of Internal Medicine / the The Journal / / Technology alpha / / URL http /
SocialTag |
Cardiac Toxicity in Chronic Fatigue Syndrome: Results from a Randomized 40-Week Multicenter Double-blind Placebo Control Trial of Rintatolimod Bruce C. Stouch, Ph.D1